Affiliation:
1. Department of Microbiology, National Veterinary Research Institute, 24-100 Pulawy, Poland
2. Department of Microbiology, National Tuberculosis and Lung Diseases Institute in Warsaw, 01-138 Warsaw, Poland
3. Pope John Paul II State School of Higher Education in Biala Podlaska, 21-500 Biała Podlaska, Poland
Abstract
Abstract
Introduction: Tuberculosis is a highly infectious disease affecting humans and animals. It is caused by the Mycobacterium tuberculosis complex (MTBC) – Mycobacterium bovis and Mycobacterium caprae, which are aetiological factors of bovine tuberculosis (bTB). In Poland, the bTB eradication programme exists. Animals diagnosed with tuberculosis are in the majority of cases not treated, but removed from their herd and then sanitary slaughtered.
Material and Methods: In total, 134 MTBC strains isolated from cattle in Poland were subjected to microbiological analysis. The resistance phenotype was tested for first-line antimycobacterial drugs used in tuberculosis treatment in humans: streptomycin, isoniazid, rifampicin, ethambutol, and pyrazinamide. The strains were isolated from tissues collected post mortem, so the test for drug resistance fulfilled only epidemiological criterion.
Results: The analysis of drug-resistance of MTBC strains revealed that strains classified as M. bovis were susceptible to 4 antimycobacterial drugs: isoniazid, rifampicin, streptomycin, and ethambutol, and resistant to pyrazynamide. The strains classified as M. caprae were sensitive to all tested drugs.
Conclusion: The results indicate that despite enormously dynamic changes in mycobacterial phenotype, Polish strains of MTBC isolated from cattle have not acquired environmental resistance. The strains classified as M. bovis are characterised by natural resistance to pyrazinamide, which is typical for this species.
Reference34 articles.
1. 1. Aranaz A., Cousins D., Mateos A., Domínguez L.: Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov. Int J Syst Evol Microbiol 2003, 53, 1785–1789.
2. 2. Bailey S.S., Crawshaw T.R., Smith N.H., Palgrave C.J.: Mycobacterium bovis infection in domestic pigs in Great Britain. Vet J 2013, 198, 391–397.
3. 3. Beltrán-Beck B., Ballestros C., Vicente J., de la Fuente J., Gortázar C.: Progress in oral vaccination against tuberculosis in its main wildlife resevoir in Iberia, the Eurasian wild boar. Vet Med Int 2012, doi: 10.1155/2012/978501.
4. 4. Bobadilla-del Valle M., Torres-González P., Cervera-Hernández M.E., Martínez-Gamboa A., Crabtree-Ramirez B., Chávez-Mazari B., Ortiz-Conchi N., Rodríguez-Cruz L., Cervantes-Sánchez A., Gudiño-Enríquez T., Cinta-Severo C., Sifuentes-Osornio J., Ponce de León A.: Trends of Mycobacterium bovis isolation and first-line anti-tuberculosis drug susceptibility profile: A fifteen-year laboratory-based surveillance. PLoS Negl Trop Dis 2015, doi: 10.1371/journal.pntd.0004124.
5. 5. Campbell T.A., Long D.B., Bazan L.R., Thomsen B.V., Robbe-Austerman S., Davey R.B., Soliz L.A., Swafford S.R., VerCauteren K.C.: Absence of Mycobacterium bovis in feral swine (Sus scrofa) from the southern Texas border region. J Wildl Dis 2011, 47, 974–978.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献